It was initially reported that the actual device was available.It has now been reported that the actual device is no longer available.Therefore, the investigation is based on evaluation of the user facility information and a retention sample from the reported product code/lot number combination.Visual inspection revealed no anomalies, such as a break, in the appearance.The retention sample was built into a circuit.Bovine blood was circulated in the circuit, while the pressure drop was determined at each flow rate.The obtained values were confirmed to meet manufacturer specifications.No obstruction inside the oxygenator module was found.After the above test, bovine blood was kept circulated for six hours.No obstruction occurred.When the circulation was ceased, the oxygenator module was flushed with saline solution.No clot was found inside the oxygenator module.The investigation result verified that the retention sample was the normal product.As a cause of this complaint, it is likely due to some factor(s), clots formed and obstructed the actual sample.With the absence of the actual sample to evaluate, the exact cause of the reported event cannot be definitively determined based on the available information.The ifu states: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system.".
|